BioSpace News Archive

Press Releases

Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept

April 16, 2025
·
3 min read
Press Releases

Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting

April 16, 2025
·
2 min read
Press Releases

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

April 16, 2025
·
8 min read
Press Releases

Chemomab Announces New Medical and Clinical Appointments

April 16, 2025
·
9 min read
Press Releases

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets

April 16, 2025
·
3 min read
Press Releases

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada

April 16, 2025
·
8 min read
Press Releases

XellSmart’s Allogeneic iPSC-derived Cell Therapies for Parkinson’s Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials

April 16, 2025
·
5 min read
Press Releases

SpineX Inc. Announces Significant Improvement in Urinary Bladder Function in Paralyzed Individuals with SCONE™ Therapy

April 16, 2025
·
2 min read
Press Releases

Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research

April 16, 2025
·
7 min read
Press Releases

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

April 16, 2025
·
9 min read